Zimmer Biomet Holdings, Inc. (ZBH)
NYSE · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $17.37B
- P/E ratio
- —
- EPS
- —
- Volume
- 1,670,046
- 52-week high
- —
- 52-week low
- —
- Open
- $91.31
- Day high
- $91.34
- Day low
- $88.76
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $8.23B | $705.1M | $3.55 |
| 2024 | $7.68B | $903.8M | $4.43 |
| 2023 | $7.39B | $1.02B | $4.88 |
| 2022 | $6.94B | $231.4M | $1.10 |
| 2021 | $6.83B | $401.6M | $1.91 |
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
- CEO
- Ivan Tornos
- Employees
- 17,000
- Country
- US
- IPO date
- Jul 25, 2001
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Zimmer Biomet Holdings, Inc.'s stock price today?
- ZBH is trading at $89.72 as of Jul 20, 2026.
- What is Zimmer Biomet Holdings, Inc.'s market cap?
- Zimmer Biomet Holdings, Inc. (ZBH) has a market capitalization of $17.37B.
- Does Zimmer Biomet Holdings, Inc. pay a dividend?
- Yes. In FY2025, Zimmer Biomet Holdings, Inc. paid $0.96 per share in dividends.
- What sector is Zimmer Biomet Holdings, Inc. in?
- Zimmer Biomet Holdings, Inc. operates in the Healthcare sector.